Tesla Advisors Discuss Divesting China Operations
The Wall Street Journal reports that Tesla advisors are discussing plans to spin off, sell, or close its China operations. Executives have been instructed to prepare for a potential separation, with the China business accounting for about 18% of sales in the first half of the year, and two major factories located in Shanghai. Event-driven funds are focusing on the construction of regulatory firewalls, with SpaceX supported as a U.S. defense contractor, while Tesla's exposure in China is under pressure. Source: Public Information
ABAB AI Insight
Elon Musk previously designed Tesla's China operations to be easily separable from its U.S. business due to geopolitical tensions. This advisor discussion directly continues that design and is linked to the merger path with SpaceX. Earlier, both JPMorgan and Morningstar warned that the China business would become a major regulatory bottleneck for the merger. In terms of capital, SpaceX's U.S. government business is expected to reach 20.9% by 2025, and the merger requires clearing Chinese customer data and dual-use technology risks. Capital and resources are leaning towards forming an independent Chinese unit with firewall capabilities or selling, while maintaining supply chain flexibility at the Shanghai factories. Similar cases can be seen in the strict separation of Boeing's commercial and defense businesses, as well as many multinational automakers accelerating supply chain decoupling from China amid U.S.-China tensions. Tesla is currently transitioning from global integration to geopolitically segmented operations. Essentially, this is a response to regulatory changes: U.S.-China security reviews are forcing asset restructuring, as companies related to defense cannot bear exposure to operations in China under ITAR export controls and CFIUS reviews, leading to a forced reconstruction of ownership boundaries. ABAB News · Cognitive Laws 1. Geopolitical risks compel asset separability 2. Establish firewalls before mergers 3. Regulatory pricing exceeds narrative.